NuVasive raises (OSIR.org.in) revenue outlook for 2008 - Forbes
Medical device maker NuVasive Inc. maintained its 2008 profit forecast, but predicted increased revenue that was above Wall Street expectations. NuVasive (nasdaq: NUVA - news - people ) now expects revenue of $245 million to $247 million, up from its
Source: www.forbes.com
Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers (Correct) - Bloomberg
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to
Source: www.bloomberg.com